Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victoza for Microvascular Myocardial Function in Type 2 Diabetes
NCT01931982Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- May 2013
- Primary completion
- Apr 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Bispebjerg and Frederiksberg Hospital. Started May 2013; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01931982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931982.